It’s one of the biggest challenges biomeds face: The relentless need for medical device testing—for ensuring that everything is working as intended in order to guarantee the highest standards of patient care. With that in mind, we reached out to three biomedical test product companies and asked them about their latest innovations and how they might help HTM teams do their jobs. Here’s what they told us.

According to a new report by MarketsandMarkets, the global medical device testing market is projected to surge from its current $8.56 billion valuation to $12.26 billion by 2023, growing at a compound annual growth rate of 6.18%.

According to a new report, the test and measurement equipment market is slated to grow from its current $23.51 billion valuation to $28.98 billion by 2023, at a CAGR of 3.55%. The healthcare test and measurement equipment market is projected to see a large percentage of this growth.

St. Charles, Mo.-based BC Group International, Inc. and Towaco, N.J.-based RTI Electronics, Inc. have inked a deal for the distribution of the RTI Imaging product line. BC Group manufactures, services, and sells biomedical testing equipment while RTI provides these services in the imaging test equipment sector.

Switzerland-based Imtmedical AG has unveiled the new CITREX H5 mobile test device. According to company officials, the CITREX H5 offers a host of features designed for biomedical engineers, independent service providers, as well as anesthesia and respiratory equipment manufacturers.